NCT01045187已完成不适用
Feasibility Study Using the Xoft Axxent Electronic Brachytherapy System for the Treatment of Endometrial Cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Xoft, Inc.
- 入组人数
- 15
- 试验地点
- 12
- 主要终点
- Assess Number of Patients Who Were Able to Complete Treatment Delivery Using the Axxent Electronic Brachytherapy System
研究概览
简要总结
Multicenter, non-randomized, feasibility study to evaluate the treatment and assess acute safety of the FDA Cleared Axxent Electronic Brachytherapy System and vaginal applicator for intracavitary vaginal cuff treatment according to the physician's current standard of care.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Most types of endometrial (uterine) cancer Stage I and Stage II (see exclusion criteria below)
- •Post hysterectomy
排除标准
- •Endometrial (uterine) cancer Stage IA Grade 1
- •Scleroderma
- •Collagen vascular disease
- •Active Lupus
结局指标
主要结局
Assess Number of Patients Who Were Able to Complete Treatment Delivery Using the Axxent Electronic Brachytherapy System
时间窗: through completion of radiation therapy
次要结局
- Assess Acute Safety Outcomes in Patients During and After Vaginal Cuff Brachytherapy Treatment With the Axxent Electronic Brachytherapy System as Incorporated in to the Physician's Current Standard of Practice(through 3 month post treatment)
- Assess Occurence Rate of Toxicities(through 3 month follow up post treatment)
研究者
研究点 (12)
Loading locations...
相似试验
已完成
不适用
Acute Assessment of the Aria CV System in Patients With WHO Groups 2 and 3 Pulmonary HypertensionPulmonary HypertensionNCT05001711Aria CV, Inc18
已完成
不适用
NEXUS™ Aortic Arch Stent Graft System First In Man StudyThoracic Aortic Arch DiseaseThoracic Aortic AneurysmNCT02365454Endospan Ltd.18
终止
不适用
Safety and Efficacy Study of the Combined Ablation Procedure to Treat Paroxysmal Atrial FibrillationParoxysmal Atrial FibrillationNCT01103674nContact Surgical Inc.1
招募中
不适用
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension SystemRight Heart DysfunctionPulmonary Arterial HypertensionPulmonary HypertensionNCT04555161Aria CV, Inc30
已完成
1 期
RENABLATE-II Feasibility Study of Catheter Based Renal Denervation to Treat Resistant Hypertension - 157Hypertension, RenalNCT02095691Biosense Webster, Inc.19